Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAS-303 in Female Patients With Stress Urinary Incontinence
NCT02906683Phase 2Completed
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Oct 2016
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TAS-303 in stress urinary incontinence (SUI), sponsored by Taiho Pharmaceutical Co., Ltd.. Started Oct 2016; status: completed.
02
Drugs
TAS-303
03
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on NCT02906683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02906683.